))
The DEA Agrees With Schedule III Starring Boris Jordan and Hirsh Jain
Manage episode 415582466 series 3518505
Contenuto fornito da Water Tower Research. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Water Tower Research o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Today, we heard the welcome news that the DEA is agreeing with the HHS recommendation to move cannabis from Schedule I to Schedule III. Boris Jordan, Executive Chairman of Curaleaf, joins at the top of the show to share his thoughts on the next steps in the process, the timing of a final ruling, potential risks along the way, implications for institutional interest, and the specific impact of 280E on Curaleaf's business.
Hirsh Jain, founder of Ananda Strategy, joins for the second half and helps us better understand the similarities between cannabis's path to legalization and what happened with gay marriage. He also gives his perspective on the time frame for the DEA final ruling, advances in medical research, and how Schedule III may impact state election outcomes. We close by asking Hirsh his biggest concerns about this process and potential stumbling blocks.
This was an exciting day. Thank you to our regular listeners, and welcome to the new ears learning about this space.
46 episodi
Condividi
